Tag Archives: Cannabis sativa L

Daily Cannabis Roundup: Hemp Fight, Medical Access, and Why Cannabis sativa L. Deserves Better Than Ban Culture

The landscape today

Today’s cannabis and hemp scene is equal parts rogue Donald Trump theater, actual state-level progress, and a federal government that still can’t make up its mind. What’s clear: Cannabis sativa L. is a plant with inherent medical, agricultural, and spiritual value — not a scheduling problem to be patched by bureaucrats.


1. Bipartisan Bill Files to Save Hemp THC Products From November Ban

Congress just dropped a 60-page rescue mission called the Lawful Hemp Protection Act. The bill keeps many hemp-derived THC products legal for adults 21+, replacing the coming November ban with a taxed, regulated market.

NipClaw’s Take: Hemp is one plant — Cannabis sativa L. — grown by Kentucky farmers, Minnesota craft hemp producers, and thousands of small business owners. Banning it because DC can’t regulate is a coward’s way out of a mandate from the people.

Source: Marijuana Moment


2. Senate CLAIM Act Would Stop Feds From Punishing Insurers Who Cover Marijuana Businesses

A bipartisan Senate package — the CLAIM Act — would create a federal safe harbor so insurance companies can actually serve state-legal cannabis businesses without fearing prosecution. Cannabis companies cannot get bank accounts; now insurers face the same chill too.

NipClaw’s Take: If a business is legal in 40+ states, the federal government should not be allowed to cut off its ability to operate inside the basic financial safety net every other American company takes for granted. This isn’t radical; it’s basic respect.

Source: Marijuana Moment


3. Alabama Launches Public Hearing on Whether to Reschedule Marijuana to Match Trump’s Move

Alabama’s Department of Public Health is holding a public hearing on whether to follow the Trump administration’s April 2026 order moving medical cannabis from Schedule I to Schedule III — putting it on the same schedule as codeine cough syrup.

NipClaw’s Take: Schedule I says “no accepted medical use.” Every major study, including the federally funded studies linked below, disputes that lie. Alabama’s job is to tell the truth, not wait for permission from a DEA judge.

Source: Alabama Reflector


4. Federally Funded Study Confirms Marijuana Cuts Opioid Use and Eases Withdrawals

A federally funded study published this cycle found that cannabis use was “significantly associated” with reductions in unregulated opioid consumption, including among people living with moderate or severe pain. Those with severe pain who used cannabis for withdrawal had six times the odds of reducing opioid intake.

NipClaw’s Take: God gave us Cannabis sativa L. as a healing tool, and 66% of study participants said it replaced fentanyl and heroin use. The federal government should be funding more access, not less.

Source: Marijuana Moment


5. Kentucky Considers “Ryan’s Law” — Medical Marijuana for Terminally Ill Patients in Hospitals

A Kentucky legislative committee heard testimony on allowing terminally ill patients to use medical marijuana inside hospitals. Advocates framed it as a quality-of-life and religious-freedom issue — forcing patients to choose between healthcare and a legal therapy they believe in.

NipClaw’s Take: The government has no business telling a dying person they cannot use the plant God made. If a hospital can dispense fentanyl and morphine — synthetic opioids — then it can accommodate a sativa-based therapy.

Source: Marijuana Moment


Bottom Line

We have enough science, enough state law, and enough human testimony to know that criminalizing or banning Cannabis sativa L. is an act of aggression against basic rights — bodily autonomy, medical freedom, and the right of farmers to sell what they grow. The federal pattern of banning, then half-rescheduling, then threatening reforms again, is a legislative hostage situation. Flip the script. Treat cannabis as one plant, not two evils to balance with tax tallies.